Bit disappointing to see their break even EBITDA target pushed to '27 but they have the cash runway. Happy to see Covid and Emirati revenue distortions wound down. Their confidence in achieving >30% CAGR is positive. I wonder if there is any buyout interest with the share price so low.
Well, JPM unwound their short pretty quickly leaving a really nice looking setup on the chart. The deferring of some of the China revenue could result in stronger than expected guidance for FY '24